Mangalam Organics has announced a board meeting to discuss the financial results for the quarter and half-year. FY25 revenue grew 7.39% to Rs 530 Cr, supported by lower input costs. EBITDA jumped 51.5% to Rs 58.6 Cr, with margin expansion of ~320 bps to 11.05%. PAT nearly tripled to Rs 12.5 Cr, lifting margins to 2.36%. Q4 revenue surged 42.5% YoY to Rs 150 Cr, and PAT doubled to Rs 5.1 Cr. The company is scaling its B2C segment with new products, broader distribution across 14 states, and e-commerce, while advancing innovation in terpene intermediates and synthetic resins.